MEDICAL DIAGNOSTIC REAGENTS, CARRIERS AND OTHER CONSUMABLES

TABLE OF CONTENTS

• MEDICAL DIAGNOSTIC REAGENTS, CHEMICALS, AND OTHER CONSUMABLES
• STUDY BACKGROUND
• STUDY GOALS AND OBJECTIVES
• INTENDED AUDIENCE
• SCOPE AND FORMAT
• METHODOLOGY AND INFORMATION SOURCES
• ANALYST CREDENTIALS
• RELATED BCC RESEARCH
• REPORTS
• MONTHLY NEWSLETTER
• BCC ON-LINE SERVICES

• SUMMARY TABLE TOTAL U.S. AND GLOBAL MARKET FOR IN-VITRO DIAGNOSTIC CHEMICALS, CARRIERS, AND CONSUMABLES, THROUGH 2008 ($ BILLIONS)
• SUMMARY FIGURE TOTAL U.S. AND GLOBAL MARKET FOR IN-VITRO DIAGNOSTIC CHEMICALS, CARRIERS, AND CONSUMABLES, 2002-2008 ($ BILLIONS)

• TYPES OF TESTS
• MICROBIOLOGICAL ANALYSIS
• CHEMICAL ANALYSIS
• IMMUNOLOGICAL ANALYSIS
• NUCLEIC ACID ANALYSIS
• TYPES OF PRODUCTS
• REAGENTS
  • Microbiological Reagents
• TABLE 1 MAJOR MICROBIOLOGICAL REAGENTS
  • Chemical Reagents
• TABLE 2 MAJOR DIAGNOSTIC CHEMICAL REAGENTS
  • Immunological Reagents
• TABLE 3 MAJOR DIAGNOSTIC IMMUNOLOGICAL REAGENTS
• TABLE 3 (CONTINUED)
  • Nucleic Acid Reagents

• OTHER CHEMICALS
  • Functional Chemicals
  • Nonfunctional Chemicals
• DISPOSABLE DEVICE CARRIERS AND OTHER CONSUMABLES
  • Disposable Device Carriers and Other Consumables (Continued)

• DIAGNOSTIC TESTING APPLICATIONS
• INFECTIOUS DISEASE TESTING
• FIGURE 1 U.S. MARKET FOR INFECTIOUS DISEASE REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)
  • Current Market
• FIGURE 2 PERCENT MARKET SHARE FOR DIAGNOSTIC TESTS FOR INFECTIOUS DISEASES BY TYPE OF TEST, 2002 (%)
• TABLE 5 U.S. INFECTIOUS DISEASE TESTING MARKET BY PRODUCT TYPE, 2002
  • Market Drivers
  • Epidemiological Trends
• TABLE 6 U.S. TRENDS IN MAJOR INFECTIOUS DISEASES, 1990 THROUGH 2002 (NUMBER OF NEW CASES ANNUALLY)
• TABLE 7 IMPACT OF EPIDEMIOLOGICAL TRENDS ON THE MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN INFECTIOUS DISEASE TESTING, 2002-2008 ($ MILLIONS)
  • Development and Commercialization of New Diagnostic Techniques
  • Threat of Bioterrorism
  • Projected Market
• TABLE 8 PROJECTED DEMAND FOR INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS, THROUGH 2008 ($ MILLIONS)
  • CANCER TESTING
• FIGURE 3 MARKET FOR CANCER TESTING REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)
  • Current Market
• FIGURE 4 DIAGNOSTIC TESTS FOR CANCER BY TYPE OF TEST, 2002 (PERCENT OF ALL TESTS BY VALUE)
• TABLE 9 U.S. CANCER TESTING MARKET BY PRODUCT TYPE, 2002 ($ BILLIONS)
  • Market Drivers
  • Demographic and Epidemiological Trends, 2002-2008
• TABLE 10 IMPACT OF DEMOGRAPHIC AND EPIDEMIOLOGICAL TRENDS ON THE MARKET FOR CANCER DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)
  • Development and Commercialization of New Diagnostic Techniques
  • Replacement Tests
  • New Applications
  • HPV Screening for Cervical Cancer
  • Mammastatin Serum Assays for Breast Cancer Screening
• TABLE 11 IMPACT OF NEW TECHNOLOGIES ON MARKET FOR CANCER DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)
  • Projected Market
• TABLE 12 PROJECTED DEMAND FOR CANCER DIAGNOSTIC PRODUCTS, THROUGH 2008 ($ MILLIONS)
  • HORMONE ANALYSIS
• FIGURE 5 MARKET FOR HORMONE TESTING REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)
  • Current Market
• FIGURE 6 HORMONE TESTS BY TYPE OF TEST, 2002 (PERCENT OF ALL TESTS BY VALUE)
• TABLE 13 U.S. HORMONE TESTING MARKET BY PRODUCT TYPE, 2002 ($ MILLIONS)
  • Market Drivers
  • Childbearing Trends
• TABLE 14 U.S. TRENDS IN FERTILITY AND CHILDBEARING, THROUGH 2002
  • Increase in Older Age Groups
• TABLE 15 TRENDS IN OLDER AGE GROUPS OF U.S. POPULATION, THROUGH 2002
  • Projected Market
• TABLE 16 IMPACT OF EPIDEMIOLOGICAL TRENDS ON MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN HORMONE TESTING, 2002-2008 ($ MILLIONS)
  • DRUG TESTING
• FIGURE 7 MARKET FOR DRUG TESTING REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)
  • Current Market
• FIGURE 8 DRUG TESTS BY TYPE OF TEST, 2002 (PERCENT OF ALL TESTS BY VALUE)
• TABLE 17 U.S. DRUG TESTING MARKET BY PRODUCT TYPE, 2002
  • Market Drivers
  • Legislation
  • Drug Abuse Rates
  • New Products and Testing Technologies
  • Growing Use of Prescription Drugs
  • Projected Market
• TABLE 18 IMPACT OF DEMAND DRIVERS ON MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN DRUG TESTING, 2002-2008
  • BLOOD/URINE TESTING
• TABLE 19 KEY BLOOD AND URINE CHEMISTRY PARAMETERS
• TABLE 19 (CONTINUED)
• FIGURE 9 MARKET FOR BLOOD AND URINE TESTING REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)
  • Current Market
• TABLE 20 U.S. BLOOD/URINE TESTING MARKET BY PRODUCT TYPE, 2002 ($ MILLIONS)
  • Market Drivers
  • At-Risk Populations
• TABLE 21 INCIDENCE OF DIABETES AMONG DIFFERENT AGE GROUPS
  • Incidence of Diabetes
  • New Products and Testing Technologies
  • Projected Market
• TABLE 22 IMPACT OF DEMAND DRIVERS ON THE MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN BLOOD/URINE CHEMISTRY TESTING, 2002-2008 ($ MILLIONS)
  • MEDICAL RESEARCH
• FIGURE 10 MARKET DIAGNOSTIC REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN MEDICAL RESEARCH, THROUGH 2008 ($ MILLIONS)
  • Current Market
• TABLE 23 U.S. MEDICAL RESEARCH TESTING MARKET BY PRODUCT TYPE, 2002 ($ MILLIONS)
  • Market Drivers and the National Institutes of Health
  • Projected Market
• TABLE 24 IMPACT OF DEMAND DRIVERS ON MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN MEDICAL RESEARCH, 2002-2008 ($ MILLIONS)
  • VETERINARY MEDICINE
• FIGURE 11 MARKET FOR VETERINARY TESTING REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)
• FIGURE 11 (CONTINUED)
  • Current Market
• TABLE 25 U.S. VETERINARY TESTING MARKET BY PRODUCT TYPE, 2002 ($ MILLIONS)
  • Market Drivers
  • Commercial Livestock Trends
• TABLE 26 TRENDS IN U.S. MEAT PRODUCTION, THROUGH 2002 (BILLION POUNDS)
  • Trends in Consumer Spending on Companion Animal Care
• TABLE 27 TRENDS IN U.S. CONSUMER SPENDING ON PET CARE, INCLUDING VETERINARY SERVICES, THROUGH 2002 ($ BILLIONS)
  • Projected Market
• TABLE 28 IMPACT OF DEMAND DRIVERS ON MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN VETERINARY DIAGNOSTIC TESTING, 2002-2008 ($ MILLIONS)
  • END-USE MARKETS
  • CLINICAL LABORATORIES
• FIGURE 12 NUMBER OF CLIA-REGISTERED CLINICAL LABORATORIES, 1993-2002
• FIGURE 13 TOTAL CLIA-REGISTERED LABORATORIES, BY TYPE, 2002 (PERCENT OF LABORATORIES REPORTING)
• FIGURE 14 DIAGNOSTIC AND OTHER CLINICAL TESTS CARRIED OUT BY TYPE OF LABORATORY, 2002 (PERCENT OF ALL TESTS, BY VALUE)
  • MEDICAL RESEARCH LABORATORIES
• TABLE 29 ENTITIES ENGAGED IN MEDICAL RESEARCH
  • VETERINARY LABORATORIES
• TABLE 30 ENTITIES ENGAGED IN VETERINARY DIAGNOSTIC ACTIVITIES
  • INDIVIDUAL CONSUMERS FOR HOME-USE MARKET
    • Individual Consumers for Home-Use Market (Continued)

• FOOD AND DRUG ADMINISTRATION
  • Premarket Clearance
  • Premarket Clearance (Continued)
  • Good Manufacturing Practices
  • Responsible Agencies
  • Center for Devices and Radiological Health
  • Center for Biologics Evaluation and Research
  • Centers for Medicare and Medicaid Services
  • State Governments
  • Not-for-Profit Organizations
  • College of American Pathologists
  • American Medical Association
  • U.S. Department of Agriculture

• SUMMARY
• FIGURE 15 TOTAL U.S. MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND CONSUMABLES, 2000-2008 ($ MILLIONS)
  • DETAILED MARKET ESTIMATES AND PROJECTIONS, 2000 – 2008
  • MARKET PROJECTION METHODOLOGY AND DATA SOURCES
  • MARKET BY APPLICATION
• TABLE 31 U.S. MARKET FOR DIAGNOSTIC CHEMICALS AND OTHER CONSUMABLES BY APPLICATION SEGMENT, THROUGH 2008 ($ MILLIONS)
• FIGURE 16 MARKET SHARES BY APPLICATION SEGMENT, 2003 AND 2008 (PERCENT OF TOTAL SALES)
  • MARKET BY PRODUCT TYPE
    • Summary
• TABLE 32 TRENDS IN OVERALL CONSUMPTION OF DIAGNOSTIC COMPONENTS BY TYPE OF PRODUCT, THROUGH 2008 ($ MILLIONS)
  • Detailed Analysis
  • Reagents
• TABLE 33 TRENDS IN OVERALL CONSUMPTION OF REAGENTS, BY TYPE OF REAGENT, THROUGH 2008 ($ MILLIONS)
• TABLE 34 LARGEST-SELLING REAGENTS, 2002-2008 ($ MILLIONS)
  • Microbiological Reagents
• TABLE 35 U.S. MARKET FOR PAP STAINS AND OTHER MICROBIOLOGICAL REAGENTS, THROUGH 2008 ($ MILLIONS)
  • Chemical Reagents
• TABLE 36 TRENDS IN U.S. MARKET FOR CHEMICAL REAGENTS, THROUGH 2008 ($ MILLIONS)
  • Immunological Reagents
• TABLE 37 TRENDS IN THE U.S. MARKET FOR IMMUNOLOGICAL REAGENTS, THROUGH 2008 ($ MILLIONS)
  • Nucleic Acid Reagents
• TABLE 38 TRENDS IN THE U.S. MARKET FOR NUCLEIC ACID REAGENTS, THROUGH 2008 ($ MILLIONS)
  • Other Chemicals
• TABLE 39 TRENDS IN THE U.S. MARKET FOR OTHER CHEMICALS, THROUGH 2008 ($ MILLIONS)
  • Device Carriers and Other Consumables
• TABLE 40 TRENDS IN THE U.S. MARKET FOR DEVICE CARRIERS AND OTHER CONSUMABLES, THROUGH 2008 ($ MILLIONS)
  • MARKET BY END-USE
• FIGURE 17 TRENDS IN DIAGNOSTIC COMPONENT END-USER SEGMENTS, 2003 AND 2008
• TABLE 41 DIAGNOSTIC COMPONENT SALES BY END-USER SEGMENT, THROUGH 2008 ($ MILLIONS)
  • LONG-TERM OUTLOOK FOR THE U.S. MARKET
  • DEVELOPMENTS THAT WILL INFLUENCE THE LONG-TERM MARKET
    • Demographic and Epidemiological Trends
    • Technology Trends
    • Economic Trends
    • Governmental/Regulatory Trends
    • Trends in the Structure of the Health-Care Industry
  • LONG-TERM MARKET PROSPECTS

• INDUSTRY STRUCTURE
• SUMMARY
• FIGURE 18 TOTAL U.S. SHIPMENTS OF DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002 (%)
  • DIAGNOSTIC REAGENTS AND CHEMICALS
    • Domestic Production
    • Industry Structure
• TABLE 42 U.S. IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURERS CLASSIFIED BY SIZE OF ESTABLISHMENT
• FIGURE 19 IN-VITRO DIAGNOSTIC PRODUCT SHIPMENTS BY SIZE OF ESTABLISHMENT (PERCENT OF TOTAL MANUFACTURERS�f SHIPMENTS)
• TABLE 43 U.S. IN-VITRO DIAGNOSTIC REAGENT MANUFACTURERS, CLASSIFIED BY PRINCIPAL PRODUCT
  • Foreign Trade
• TABLE 44 NET U.S. IMPORTS OF PHARMACEUTICALS AND MEDICINES, 1997-2000 ($ BILLIONS)
• TABLE 45 DOMESTIC PRODUCTION AND NET IMPORTS OF IN-VITRO DIAGNOSTIC PRODUCTS, 2000-2003 ($ BILLIONS)
  • DEVICE CARRIERS AND CONSUMABLES
    • Domestic Production
    • Industry Structure
• FIGURE 20 U.S. IN-VITRO DIAGNOSTIC ASSAY SYSTEM COMPONENTS SUPPLIERS (TOTAL NUMBER OF COMPANIES IN EACH CATEGORY)
  • PERFORMANCE
  • SALES
• TABLE 46 SELECTED DIAGNOSTIC PRODUCT COMPANIES�f SALES PERFORMANCE, THROUGH 2002 ($ MILLIONS)
• TABLE 47 COMPANY SIZE VS. SALES PERFORMANCE, THROUGH 2002
  • PROFITABILITY
• TABLE 48 COMPANY SIZE VS. PROFITABILITY, 2000-2002
  • COMPETITION AND MARKET SHARES
  • CLINICAL AND RESEARCH MARKET
• FIGURE 21 U.S. CLINICAL AND RESEARCH DIAGNOSTIC COMPONENT MARKET LEADERS, 2002 (PERCENT OF TOTAL SALES)
• TABLE 49 CLINICAL AND RESEARCH DIAGNOSTIC COMPONENT VENDORS�f U.S. SALES, 2002
  • VETERINARY MARKET
• FIGURE 22 U.S. VETERINARY DIAGNOSTIC COMPONENT MARKET LEADERS, 2002 (PERCENT OF TOTAL SALES)
• TABLE 50 VETERINARY DIAGNOSTIC COMPONENT VENDORS�f U.S. SALES, 2002
  • SALES AND DISTRIBUTION
• FIGURE 23 U.S. DISTRIBUTION CHANNELS FOR DIAGNOSTIC COMPONENTS (PERCENT OF TOTAL SALES THROUGH EACH CHANNEL)
  • TRENDS IN OWNERSHIP AND INDUSTRY STRUCTURE
    • Trends in Ownership and Industry Structure (Continued)

• GLOBAL MARKET ESTIMATES AND PROJECTIONS, 2002 TO 2008
• FIGURE 24 TRENDS IN THE GLOBAL MARKET FOR DIAGNOSTIC REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ BILLIONS)
  • LONG-TERM TRENDS IN GLOBAL MARKETS

• DIAGNOSTIC REAGENTS, CHEMICALS, AND KITS
• ABAXIS, INC.
• TABLE 51 ABAXIS, INC. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)
  • ABBOTT LABORATORIES, INC.
• TABLE 52 ABBOTT LABORATORIES, INC. SALES OF DIAGNOSTIC PRODUCTS, THROUGH 2002 ($ MILLIONS)
  • ACON LABORATORIES, INC.
  • AFFYMETRIX, INC.
  • BAYER DIAGNOSTICS
  • BECKMAN COULTER, INC.
• TABLE 53 BECKMAN COULTER, INC. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)
• TABLE 54 BECKMAN COULTER, INC. SALES BY GEOGRAPHICAL REGION, 2002
  • BECTON DICKINSON & CO.
• TABLE 55 BECTON DICKINSON & CO. CLINICAL LABORATORY SOLUTIONS SEGMENT REVENUES, THROUGH 2002 ($ MILLIONS)
  • BIOCHECK, INC.
  • BIOMEDICAL DIAGNOSTICS, LLC
  • CYTYC CORP.
• TABLE 56 CYTYC CORP. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)
  • DADE BEHRING
• TABLE 57 DADE BEHRING SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)
  • DIADEXUS
  • GENZYME DIAGNOSTICS
  • HEMAGEN DIAGNOSTICS, INC.
  • HESKA CORP.
• TABLE 58 HESKA CORP. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)
  • IDEXX LABORATORIES, INC.
• TABLE 59 IDEXX LABORATORIES, INC. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)
  • INFECTIO DIAGNOSTICS, INC.
  • INOVA DIAGNOSTICS, INC.
  • IVAX DIAGNOSTICS, INC.
• TABLE 60 IVAX DIAGNOSTICS, INC. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)
  • MERIDIAN BIOSCIENCE, INC.
• TABLE 61 MERIDIAN BIOSCIENCE, INC. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)
  • MICROMEDX
  • MYRIAD GENETIC LABORATORIES, INC.
  • NEW HORIZONS DIAGNOSTICS CORP.
  • ORASURE TECHNOLOGIES, INC.
  • ORTHO-CLINICAL DIAGNOSTICS
  • PHARMACIA
  • QUEST DIAGNOSTICS, INC.
  • QIAGEN N.V.
  • ROCHE DIAGNOSTICS
• TABLE 62 ROCHE DIAGNOSTICS SALES BY BUSINESS SEGMENT, 2002
  • SYNBIOTICS CORP.
• TABLE 63 SYNBIOTICS CORP. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)
  • VYSIS, INC.
  • WORLDWIDE MEDICAL CORP.
  • DEVICE CARRIERS
  • DIAGNOSTIC LAMINATIONS ENGINEERING
  • EVERGREEN SCIENTIFIC, INC.
  • EXCEL SCIENTIFIC, INC.
  • GLOBE SCIENTIFIC, INC.
  • INTEGRATED BIOMEDICAL TECHNOLOGY
  • MILLENIUM DIAGNOSTICS, LTD.
  • NORTH AMERICAN BIOMEDICAL
  • SCHLEICHER & SCHUELL BIOSCIENCE
  • VIROTEK, LLC
  • WHATMAN, PLC

• MAJOR DIAGNOSTIC TESTS
• INFECTIOUS DISEASE TESTS
  • Bacterial Tests
• TABLE 64 COMMON TYPES OF BACTERIAL INFECTIOUS DISEASES AND ASSOCIATED DIAGNOSTIC TESTS
  • Staphylococcus
  • Helicobacter Pylori
  • Chlamydia
  • Streptococcus
  • Treponema
  • Neisseria Gonorrhea
  • Borrelia
  • Escherichia
  • Shigella
  • Legionella
  • Fungal Tests
• TABLE 65 COMMON TYPES OF FUNGAL INFECTIOUS DISEASES AND ASSOCIATED DIAGNOSTIC TESTS
• TABLE 65 (CONTINUED)
  • Aspergillus
  • Blastomyces
  • Candida
  • Coccidomycosis
  • Cryptococcosis
  • Histoplasmosis
  • Sporotrichosis
  • Viral Tests
• TABLE 66 COMMON TYPES OF VIRAL DISEASES AND ASSOCIATED DIAGNOSTIC TESTS
  • Cytomegalovirus
  • Epstein-Barr Virus
  • Hepatitis
  • Human Immunodeficiency Virus (HIV)
  • Influenza
  • Paramyxovirus
  • Rubella
  • Varicella Zoster
  • Protozoan Tests
• TABLE 67 COMMON TYPES OF PROTOZOAL INFECTIOUS DISEASES AND ASSOCIATED DIAGNOSTIC TESTS
  • Cryptosporidiosis
  • Giardiasis
  • Amoebic Dysentery
  • Toxoplasmosis
  • Malaria
  • Trichomoniasis
  • CANCER TESTING
    • FDA-Approved Tests
• TABLE 68 COMMON TYPES OF CANCER AND ASSOCIATED DIAGNOSTIC TESTS
• TABLE 68 (CONTINUED)
  • Cervical Cancer Tests
  • Pap Smear
  • Human Papilloma Virus Test
  • Colorectal Cancer Tests
  • Fecal Occult Blood Test
  • Bladder Cancer Tests
  • Bladder Tumor Antigen Test
  • Nuclear Matrix Protein Test for Bladder Cancer
  • Genetic Markers for Bladder Cancer Test
  • Breast Cancer Tests
  • CA (Cancer Antigen) 15-3 Test
  • CA 27-29 (Truquant) Test
  • Estrogen and Progesterone Receptor Tests
  • HER-2/Neu Test
  • Central Nervous System
  • Neuron-Specific Enolase Test
  • Colorectal Cancer
  • Carcinoembryonic Antigen Test
  • Gastric/Pancreatic/Stomach Cancer
  • Ca 19-9 Test
  • Liver Cancer
  • Alpha-Fetoprotein Test
  • Metastatic Melanoma
  • S-100 Test
  • Multiple Myeloma
  • Nasophryngeal Cancer and Epstein-Barr Virus Antibodies Test
  • Ovarian Cancer
  • CA-125 Test
  • CA 72-4 Test
  • Prostate Cancer
  • Prostatic-Specific Antigen Test
  • Testicular Cancer
  • Human Chronic Gonadotropin Test
  • Thyroid Medullary Carcinoma
  • Calcitonin Test
  • New Tests
  • Genetic Test for HPV
  • Genetic Test for Potential Recurrence of Breast Cancer
  • Genetic Test for Colon Cancer
  • Genetic Test for Lung Cancer

SUMMARY TABLE:

TOTAL U.S. AND GLOBAL MARKET FOR IN-VITRO DIAGNOSTIC CHEMICALS, CARRIERS, AND CONSUMABLES, THROUGH 2008 ($ BILLIONS)

TABLE 1 MAJOR MICROBIOLOGICAL REAGENTS

TABLE 2 MAJOR DIAGNOSTIC CHEMICAL REAGENTS

TABLE 3 MAJOR DIAGNOSTIC IMMUNOLOGICAL REAGENTS

TABLE 4 DIAGNOSTIC NUCLEIC ACID REAGENTS

TABLE 5 U.S. INFECTIOUS DISEASE TESTING MARKET BY PRODUCT TYPE, 2002

TABLE 6 U.S. TRENDS IN MAJOR INFECTIOUS DISEASES, 1990 THROUGH 2002 (NUMBER OF NEW CASES ANNUALLY)

TABLE 7 IMPACT OF EPIDEMIOLOGICAL TRENDS ON THE MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN INFECTIOUS DISEASE TESTING, 2002-2008 ($ MILLIONS)

TABLE 8 PROJECTED DEMAND FOR INFECTIOUS DISEASE DIAGNOSTIC PRODUCTS, THROUGH 2008 ($ MILLIONS)

TABLE 9 U.S. CANCER TESTING MARKET BY PRODUCT TYPE, 2002 ($ BILLIONS)

TABLE 10 IMPACT OF DEMOGRAPHIC AND EPIDEMIOLOGICAL TRENDS ON THE MARKET FOR CANCER DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)

TABLE 11 IMPACT OF NEW TECHNOLOGIES ON MARKET FOR CANCER DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)

TABLE 12 PROJECTED DEMAND FOR CANCER DIAGNOSTIC PRODUCTS, THROUGH 2008 ($ MILLIONS)

TABLE 13 U.S. HORMONE TESTING MARKET BY PRODUCT TYPE, 2002 ($ MILLIONS)

TABLE 14 U.S. TRENDS IN FERTILITY AND CHILDBEARING, THROUGH 2002

TABLE 15 TRENDS IN OLDER AGE GROUPS OF U.S. POPULATION, THROUGH 2002

TABLE 16 IMPACT OF EPIDEMIOLOGICAL TRENDS ON MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN HORMONE TESTING, 2002-2008 ($ MILLIONS)

TABLE 17 U.S. DRUG TESTING MARKET BY PRODUCT TYPE, 2002

TABLE 18 IMPACT OF DEMAND DRIVERS ON MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN DRUG TESTING, 2002-2008

TABLE 19 KEY BLOOD AND URINE CHEMISTRY PARAMETERS

TABLE 20 U.S. BLOOD/URINE TESTING MARKET BY PRODUCT TYPE, 2002 ($ MILLIONS)

TABLE 21 INCIDENCE OF DIABETES AMONG DIFFERENT AGE GROUPS

TABLE 22 IMPACT OF DEMAND DRIVERS ON THE MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN BLOOD/URINE CHEMISTRY TESTING, 2002-2008 ($ MILLIONS)

TABLE 23 U.S. MEDICAL RESEARCH TESTING MARKET BY PRODUCT TYPE, 2002 ($ MILLIONS)

TABLE 24 IMPACT OF DEMAND DRIVERS ON MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN MEDICAL RESEARCH, 2002-2008 ($ MILLIONS)

TABLE 25 U.S. VETERINARY TESTING MARKET BY PRODUCT TYPE, 2002 ($ MILLIONS)

TABLE 26 TRENDS IN U.S. MEAT PRODUCTION, THROUGH 2002 (BILLION POUNDS)

TABLE 27 TRENDS IN U.S. CONSUMER SPENDING ON PET CARE, INCLUDING VETERINARY SERVICES, THROUGH 2002 ($ BILLIONS)

TABLE 28 IMPACT OF DEMAND DRIVERS ON MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN VETERINARY DIAGNOSTIC TESTING, 2002-2008 ($ MILLIONS)

TABLE 29 ENTITIES ENGAGED IN MEDICAL RESEARCH

TABLE 30 ENTITIES ENGAGED IN VETERINARY DIAGNOSTIC ACTIVITIES

TABLE 31 U.S. MARKET FOR DIAGNOSTIC CHEMICALS AND OTHER CONSUMABLES BY APPLICATION SEGMENT, THROUGH 2008 ($ MILLIONS)

TABLE 32 TRENDS IN OVERALL CONSUMPTION OF DIAGNOSTIC COMPONENTS BY TYPE OF PRODUCT, THROUGH 2008 ($ MILLIONS)

TABLE 33 TRENDS IN OVERALL CONSUMPTION OF REAGENTS, BY TYPE OF REAGENT, THROUGH 2008 ($ MILLIONS)

TABLE 34 LARGEST-SELLING REAGENTS, 2002-2008 ($ MILLIONS)

TABLE 35 U.S. MARKET FOR PAP STAINS AND OTHER MICROBIOLOGICAL REAGENTS, THROUGH 2008 ($ MILLIONS)

TABLE 36 TRENDS IN U.S. MARKET FOR CHEMICAL REAGENTS, THROUGH 2008 ($ MILLIONS)

TABLE 37 TRENDS IN THE U.S. MARKET FOR IMMUNOLOGICAL REAGENTS, THROUGH 2008 ($ MILLIONS)

TABLE 38 TRENDS IN THE U.S. MARKET FOR NUCLEIC ACID REAGENTS, THROUGH 2008 ($ MILLIONS)

TABLE 39 TRENDS IN THE U.S. MARKET FOR OTHER CHEMICALS, THROUGH 2008 ($ MILLIONS)

TABLE 40 TRENDS IN THE U.S. MARKET FOR DEVICE CARRIERS AND OTHER CONSUMABLES, THROUGH 2008 ($ MILLIONS)

TABLE 41 DIAGNOSTIC COMPONENT SALES BY END-USER SEGMENT, THROUGH 2008 ($ MILLIONS)

TABLE 42 U.S. IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURERS CLASSIFIED BY SIZE OF ESTABLISHMENT

TABLE 43 U.S. IN-VITRO DIAGNOSTIC REAGENT MANUFACTURERS, CLASSIFIED BY PRINCIPAL PRODUCT

TABLE 44 NET U.S. IMPORTS OF PHARMACEUTICALS AND MEDICINES, 1997-2000 ($ BILLIONS)

TABLE 45 DOMESTIC PRODUCTION AND NET IMPORTS OF IN-VITRO DIAGNOSTIC PRODUCTS, 2000-2003 ($ BILLIONS)

TABLE 46 SELECTED DIAGNOSTIC PRODUCT COMPANIES�f SALES PERFORMANCE, THROUGH 2002 ($ MILLIONS)

TABLE 47 COMPANY SIZE VS. SALES PERFORMANCE, THROUGH 2002

TABLE 48 COMPANY SIZE VS. PROFITABILITY, 2000-2002

TABLE 49 CLINICAL AND RESEARCH DIAGNOSTIC COMPONENT VENDORS�f U.S. SALES, 2002

TABLE 50 VETERINARY DIAGNOSTIC COMPONENT VENDORS�f U.S. SALES, 2002

TABLE 51 ABAXIS, INC. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)

TABLE 52 ABBOTT LABORATORIES, INC. SALES OF DIAGNOSTIC PRODUCTS, THROUGH 2002 ($ MILLIONS)

TABLE 53 BECKMAN COULTER, INC. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)

TABLE 54 BECKMAN COULTER, INC. SALES BY GEOGRAPHICAL REGION, 2002

TABLE 55 BECTON DICKINSON & CO. CLINICAL LABORATORY SOLUTIONS SEGMENT REVENUES, THROUGH 2002 ($ MILLIONS)

TABLE 56 CYTYC CORP. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)

TABLE 57 DADE BEHRING SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)

TABLE 58 HESKA CORP. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)

TABLE 59 IDEXX LABORATORIES, INC. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)

TABLE 60 IVAX DIAGNOSTICS, INC. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)

TABLE 61 MERIDIAN BIOSCIENCE, INC. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)

TABLE 62 ROCHE DIAGNOSTICS SALES BY BUSINESS SEGMENT, 2002

TABLE 63 SYNBIOTICS CORP. SELECTED FINANCIAL DATA, THROUGH 2002 ($ MILLIONS)

TABLE 64 COMMON TYPES OF BACTERIAL INFECTIOUS DISEASES AND ASSOCIATED DIAGNOSTIC TESTS

TABLE 65 COMMON TYPES OF FUNGAL INFECTIOUS DISEASES AND ASSOCIATED DIAGNOSTIC TESTS

TABLE 66 COMMON TYPES OF VIRAL DISEASES AND ASSOCIATED DIAGNOSTIC TESTS

TABLE 67 COMMON TYPES OF PROTOZOAL INFECTIOUS DISEASES AND ASSOCIATED DIAGNOSTIC TESTS

TABLE 68 COMMON TYPES OF CANCER AND ASSOCIATED DIAGNOSTIC TESTS

LIST OF FIGURES

SUMMARY FIGURE:

TOTAL U.S. AND GLOBAL MARKET FOR IN-VITRO DIAGNOSTIC CHEMICALS, CARRIERS, AND CONSUMABLES, 2002-2008 ($ BILLIONS)

FIGURE 1 U.S. MARKET FOR INFECTIOUS DISEASE REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)

FIGURE 2 PERCENT MARKET SHARE FOR DIAGNOSTIC TESTS FOR INFECTIOUS DISEASES BY TYPE OF TEST, 2002 (%)

FIGURE 3 MARKET FOR CANCER TESTING REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)

FIGURE 4 DIAGNOSTIC TESTS FOR CANCER BY TYPE OF TEST, 2002 (PERCENT OF ALL TESTS BY VALUE)

FIGURE 5 MARKET FOR HORMONE TESTING REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)

FIGURE 6 HORMONE TESTS BY TYPE OF TEST, 2002 (PERCENT OF ALL TESTS BY VALUE)

FIGURE 7 MARKET FOR DRUG TESTING REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)

FIGURE 8 DRUG TESTS BY TYPE OF TEST, 2002 (PERCENT OF ALL TESTS BY VALUE)

FIGURE 9 MARKET FOR BLOOD AND URINE TESTING REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)

FIGURE 10 MARKET DIAGNOSTIC REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES USED IN MEDICAL RESEARCH, THROUGH 2008 ($ MILLIONS)

FIGURE 11 MARKET FOR VETERINARY TESTING REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ MILLIONS)

FIGURE 12 NUMBER OF CLIA-REGISTERED CLINICAL LABORATORIES, 1993-2002

FIGURE 13 TOTAL CLIA-REGISTERED LABORATORIES, BY TYPE, 2002 (PERCENT OF LABORATORIES REPORTING)

FIGURE 14 DIAGNOSTIC AND OTHER CLINICAL TESTS CARRIED OUT BY TYPE OF LABORATORY, 2002 (PERCENT OF ALL TESTS, BY VALUE)

FIGURE 15 TOTAL U.S. MARKET FOR DIAGNOSTIC CHEMICALS, CARRIERS, AND CONSUMABLES, 2000-2008 ($ MILLIONS)

FIGURE 16 MARKET SHARES BY APPLICATION SEGMENT, 2003 AND 2008 (PERCENT OF TOTAL SALES)

FIGURE 17 TRENDS IN DIAGNOSTIC COMPONENT END-USER SEGMENTS, 2003 AND 2008

FIGURE 18 TOTAL U.S. SHIPMENTS OF DIAGNOSTIC CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002 (%)

FIGURE 19 IN-VITRO DIAGNOSTIC PRODUCT SHIPMENTS BY SIZE OF ESTABLISHMENT (PERCENT OF TOTAL MANUFACTURERS�f SHIPMENTS)

FIGURE 20 U.S. IN-VITRO DIAGNOSTIC ASSAY SYSTEM COMPONENTS SUPPLIERS (TOTAL NUMBER OF COMPANIES IN EACH CATEGORY)

FIGURE 21 U.S. CLINICAL AND RESEARCH DIAGNOSTIC COMPONENT MARKET LEADERS, 2002 (PERCENT OF TOTAL SALES)

FIGURE 22 U.S. VETERINARY DIAGNOSTIC COMPONENT MARKET LEADERS, 2002 (PERCENT OF TOTAL SALES)

FIGURE 23 U.S. DISTRIBUTION CHANNELS FOR DIAGNOSTIC COMPONENTS (PERCENT OF TOTAL SALES THROUGH EACH CHANNEL)

FIGURE 24 TRENDS IN THE GLOBAL MARKET FOR DIAGNOSTIC REAGENTS, CHEMICALS, CARRIERS, AND OTHER CONSUMABLES, 2002-2008 ($ BILLIONS)